The FDA has just handed an advantage to GlaxoSmithKline’s triple therapy for chronic obstructive pulmonary disease (COPD) by rejecting AstraZeneca’s PT010, a close competitor. AZ has confirmed that ...
The accelerating speed of change within the pharmaceutical launch environment raises considerable challenges for launch excellence, as companies grapple with a complex and ever-changing world. Today’s ...
Glenmark Pharmaceuticals Limited was incorporated on November 18, 1977. The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological ...
Applying to MBA programs can be a daunting process. There are many tasks to prioritize, manage, and complete, and sometimes it can feel overwhelming trying to keep track of it all. Our hope is that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback